MGRM READ THE FULL MGRM RESEARCH REPORT On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that ...

Monogram Technologies Inc. (NASDAQ:MGRM) (”Monogram” or the “Company”), an AI-driven robotics company focused on improving ...

Analysts at Zacks Small Cap issued their Q1 2025 earnings per share (EPS) estimates for shares of Monogram Orthopaedics in a ...

Roth MKM raised the firm’s price target on Monogram Orthopaedics (MGRM) to $5.40 from $4 and keeps a Buy rating on the shares.Light Up your ...

On Monday, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Monogram Technologies Inc.’s (NASDAQ:MGRM ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hyperfine (HYPR – Research Report) and Monogram Orthopaedics ...

Stock analysts at Roth Capital boosted their Q1 2025 earnings per share (EPS) estimates for shares of Monogram Orthopaedics ...

MGRM READ THE FULL MGRM RESEARCH REPORT 4th Quarter and Full Year 2024 Financial Results Monogram (NASDAQ:MGRM) reported 4th ...

Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).

MONOGRAM ORTHOPAEDICS ($MGRM) posted quarterly earnings results on Wednesday, March 12th. The company reported earnings of -$0.08 per share, beating estimates of -$0. ...

The company continues to direct its resources, focusing on commercializing the mBôs TKA System as capital efficiently as possible. Price Action: MGRM stock closed at $2.33 on Friday.

About Monogram Technologies Inc. Monogram Technologies (NASDAQ:MGRM) is an AI-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is ...